Circular RNA UBR1 promotes the proliferation, migration, and invasion but represses apoptosis of lung cancer cells via modulating microRNA-545-5p/SSFA2 axis

References

• Ho JC, Leung CC. Management of co-existent tuberculosis and lung cancer. Lung Cancer. 2018;122:83–87. 2018/ 07/24.
   PubMed Web of Science ®Google Scholar
• Osuoha CA, Callahan KE, Ponce CP, et al. Disparities in lung cancer survival and receipt of surgical treatment. Lung Cancer. 2018;122:54–59. 2018/ 07/24.
   PubMed Web of Science ®Google Scholar
• Hasan N, Kumar R, Kavuru MS. Lung cancer screening beyond low-dose computed tomography: the role of novel biomarkers. Lung. 2014;192:639–648. 2014/ 08/12.
   PubMed Web of Science ®Google Scholar
• Walter JE, Heuvelmans MA, de Bock GH, et al. Relationship between the number of new nodules and lung cancer probability in incidence screening rounds of CT lung cancer screening: the Nelson study. Lung Cancer. 2018;125:103–108. 2018/ 11/16.
   PubMed Web of Science ®Google Scholar
• Sørli K, Thorvaldsen SM, Hatlen P. Use of inhaled corticosteroids and the risk of lung cancer, the HUNT study. Lung. 2018;196:179–184. 2018/02/11.
   PubMed Web of Science ®Google Scholar
• Yuquan B, Wulin S, Minglin Z, et al. Combined detection of estrogen and tumor markers is an important reference factor in the diagnosis and prognosis of lung cancer. J Cell Biochem. 2019;120:105–114.
   PubMed Web of Science ®Google Scholar
• Kristensen LS, Hansen TB, Venø MT, et al. Circular RNAs in cancer: opportunities and challenges in the field. Oncogene. 2018;37:555–565. 2017/ 10/11.
   PubMed Web of Science ®Google Scholar
• Shang Q, Yang Z, Jia R, et al. The novel roles of circRNAs in human cancer. Mol Cancer. 2019;18:6. 2019/01/11.
   PubMed Web of Science ®Google Scholar
• Panda AC. Circular RNAs act as miRNA sponges. Adv Exp Med Biol. 2018;1087:67–79. 2018/ 09/28.
   PubMed Web of Science ®Google Scholar
• Tang Q, Hann SS. Biological roles and mechanisms of circular RNA in human cancers. Onco Targets Ther. 2020;13:2067–2092. 2020/03/27.
   PubMed Web of Science ®Google Scholar
• Liu Q, Cao G, Wan Y, et al. Hsa_circ_0001073 targets miR-626/LIFR axis to inhibit lung cancer progression. Environ Toxicol. 2021;36:1052–1060. 2021/ 01/22.
   PubMed Web of Science ®Google Scholar
• Yuan Y, Zhou X, Kang Y, et al. Circ-CCS is identified as a cancer-promoting circRNA in lung cancer partly by regulating the miR-383/E2F7 axis. Life Sci. 2021;267:118955. 2020/ 12/29.
   PubMed Web of Science ®Google Scholar
• Lee YT, Tan YJ, Oon CE. Molecular targeted therapy: treating cancer with specificity. Eur J Pharmacol. 2018;834:188–196. 2018/ 07/23.
   PubMed Web of Science ®Google Scholar
• Rong B, Yang S. Molecular mechanism and targeted therapy of Hsp90 involved in lung cancer: new discoveries and developments (Review). Int J Oncol. 2018;52:321–336. 2017/ 12/06.
   PubMed Web of Science ®Google Scholar
• Zhang L, Sun D, Zhang J, et al. Circ-UBR1 facilitates proliferation, metastasis, and inhibits apoptosis in breast cancer by regulating the miR-1299/CCND1 axis. Life Sci. 2021;266:118829. 2020/ 12/02.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Cong L, Lukiw WJ. Plant and animal microRNAs (miRNAs) and their potential for inter-kingdom communication. Cell Mol Neurobiol. 2018;38:133–140. 2017/ 09/08.
   PubMed Web of Science ®Google Scholar
• Kong YJ, Tan XX, Zhang Y, et al. MiR-141 promotes cell proliferation and invasion in non-small cell lung cancer by targeting KLF9. Eur Rev Med Pharmacol Sci. 2019;23:10370–10378. 2019/12/17.
   PubMed Web of Science ®Google Scholar
• Wang X, Shi J, Niu Z, et al. MiR-216a-3p regulates the proliferation, apoptosis, migration, and invasion of lung cancer cells via targeting COPB2. Biosci Biotechnol Biochem. 2020;84:2014–2027. 2020/07/04.
   PubMed Web of Science ®Google Scholar
• Xu CM, Chen LX, Gao F, et al. MiR-431 suppresses proliferation and metastasis of lung cancer via down-regulating DDX5. Eur Rev Med Pharmacol Sci. 2019;23:699–707. 2019/02/06.
   PubMed Web of Science ®Google Scholar
• Miao Z, Liu S, Xiao X, et al. LINC00342 regulates cell proliferation, apoptosis, migration and invasion in colon adenocarcinoma via miR-545-5p/MDM2 axis. Gene. 2020;743:144604. 2020/03/28.
   PubMed Web of Science ®Google Scholar
• Zhu A, Li X, Wu H, et al. Molecular mechanism of SSFA2 deletion inhibiting cell proliferation and promoting cell apoptosis in glioma. Pathol Res Pract. 2019;215:600–606. 2019/02/05.
   PubMed Web of Science ®Google Scholar
• Hongyu W, Fangjuan L, Ren Z. miR-338-5p inhibits cell growth and migration via inhibition of the METTL3/m6A/c-Myc pathway in lung cancer. Acta Biochim Biophys Sin (Shanghai). 2021;53:304–316.
   PubMed Web of Science ®Google Scholar
• Yangling X, Tiantian J, Changgang W, et al. CircAKT3 inhibits glycolysis balance in lung cancer cells by regulating miR-516b-5p/STAT3 to inhibit cisplatin sensitivity. Biotechnol Lett. 2020;42:1123–1135.
   PubMed Web of Science ®Google Scholar
• Tao W, Shan C, Na FX, et al. miR-219a-5p enhances the radiosensitivity of non-small cell lung cancer cells through targeting CD164. Biosci Rep. 2020;40:undefined.
   Web of Science ®Google Scholar
• Cheng A, Guangzhi M, Yunfu D, et al. Nm23-H1 inhibits lung cancer bone-specific metastasis by upregulating miR-660-5p targeted SMARCA5. Thorac Cancer. 2020;11:640–650.
   PubMed Web of Science ®Google Scholar
• Yong M, Jia-Xi H, Mei Z, et al. Circ0001320 inhibits lung cancer cell growth and invasion by regulating TNFAIP1 and TPM1 expression through sponging miR-558. Hum Cell. 2021;34:468–477.
   PubMed Web of Science ®Google Scholar
• Wuming W, Lin L, Long Z. LINC00184 plays an oncogenic role in non-small cell lung cancer via regulation of the miR-524-5p/HMGB2 axis. J Cell Mol Med. 2021;undefined:undefined.
   Google Scholar
• Ran G, Tongchen H, Yanheng L, et al. Long non-coding RNA PRNCR1 modulates non-small cell lung cancer cell proliferation, apoptosis, migration, invasion, and EMT through PRNCR1/miR-126-5p/MTDH axis. Biosci Rep. 2020;40:undefined.
   Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57–70. 2000/01/27.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–674. 2011/03/08.
   PubMed Web of Science ®Google Scholar
• Xu Z, Xiang W, Chen W, et al. Circ-IGF1R inhibits cell invasion and migration in non-small cell lung cancer. Thorac Cancer. 2020;11:875–887. 2020/02/29.
   PubMed Web of Science ®Google Scholar
• She Y, Han Y, Zhou G, et al. hsa_circ_0062389 promotes the progression of non-small cell lung cancer by sponging miR-103a-3p to mediate CCNE1 expression. Cancer Genet. 2020;241:12–19. 2020/ 01/22.
   PubMed Web of Science ®Google Scholar
• Wu Z, Gong Q, Yu Y, et al. Knockdown of circ-ABCB10 promotes sensitivity of lung cancer cells to cisplatin via miR-556-3p/AK4 axis. BMC Pulm Med. 2020;20:10. 2020/01/15.
   PubMed Web of Science ®Google Scholar
• Rupaimoole R, Slack FJ. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov. 2017;16:203–222. 2017/ 02/18.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Yang Q, Wang S. MicroRNAs: a new key in lung cancer. Cancer Chemother Pharmacol. 2014;74:1105–1111. 2014/ 08/20.
   PubMed Web of Science ®Google Scholar
• Bos JL, Fearon ER, Hamilton SR, et al. Prevalence of ras gene mutations in human colorectal cancers. Nature. 1987;327:293–297. 1987/05/03.
   PubMed Web of Science ®Google Scholar
• Cho JY, Kim JH, Lee YH, et al. Correlation between K-ras gene mutation and prognosis of patients with nonsmall cell lung carcinoma. Cancer. 1997;79:462–467. 1997/02/01.
   PubMed Web of Science ®Google Scholar
• Karapetis CS, Khambata-Ford S, Jonker DJ, et al. K-ras mutations and benefit from cetuximab in advanced colorectal cancer. N Engl J Med. 2008;359:1757–1765. 2008/10/24.
   PubMed Web of Science ®Google Scholar
• Okayama A, Kimura Y, Miyagi Y, et al. Relationship between phosphorylation of sperm-specific antigen and prognosis of lung adenocarcinoma. J Proteomics. 2016;139:60–66. 2016/03/08.
   PubMed Web of Science ®Google Scholar
• Inokuchi J, Komiya M, Baba I, et al. Deregulated expression of KRAP, a novel gene encoding actin-interacting protein, in human colon cancer cells. J Hum Genet. 2004;49:46–52. 2003/ 12/16.
   PubMed Web of Science ®Google Scholar
• Fujimoto T, Miyasaka K, Koyanagi M, et al. Altered energy homeostasis and resistance to diet-induced obesity in KRAP-deficient mice. PloS One. 2009;4:e4240. 2009/01/22.
   PubMed Web of Science ®Google Scholar
• Lemmon MA, Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell. 2010;141:1117–1134. 2010/07/07.
   PubMed Web of Science ®Google Scholar
• Logue JS, Morrison DK. Complexity in the signaling network: insights from the use of targeted inhibitors in cancer therapy. Genes Dev. 2012;26:641–650. 2012/ 04/05.
   PubMed Web of Science ®Google Scholar